The response in vitro, of continuous cultures of human lymphoblasts (CCRF-CEM cells) to chemotherapeutic agents.
D000818:Animals; D001377:Azaserine / Q000494:pharmacology; D002701:Chloramphenicol / Q000494:pharmacology; D003470:Culture Media; D046508:Culture Techniques; D003520:Cyclophosphamide / Q000494:pharmacology; D003561:Cytarabine / Q000494:pharmacology; D003609:Dactinomycin / Q000494:pharmacology; D003857:Deoxyuridine / Q000494:pharmacology; D005467:Floxuridine / Q000494:pharmacology; D005472:Fluorouracil / Q000494:pharmacology; D006801:Humans; D006854:Hydrocortisone / Q000494:pharmacology; D008214:Lymphocytes / Q000187:drug effects*; D008466:Mechlorethamine / Q000494:pharmacology; D015122:Mercaptopurine / Q000494:pharmacology; D008727:Methotrexate / Q000494:pharmacology; D008937:Mitomycins / Q000494:pharmacology; D011691:Puromycin / Q000494:pharmacology; D013936:Thymidine / Q000494:pharmacology; D014227:Triazines / Q000494:pharmacology; D014750:Vincristine / Q000494:pharmacology
D003470:Culture Media; D008937:Mitomycins; D014227:Triazines; D005467:Floxuridine; D003561:Cytarabine; D003609:Dactinomycin; D011691:Puromycin; D008466:Mechlorethamine; D014750:Vincristine; D002701:Chloramphenicol; D001377:Azaserine; D003520:Cyclophosphamide; D015122:Mercaptopurine; D005472:Fluorouracil; D013936:Thymidine; D003857:Deoxyuridine; D006854:Hydrocortisone; D008727:Methotrexate